Jaime Kulisevsky
Jaime Kulisevsky, MD, PhD
Prof. Dr. Jaime Kulisevsky is presently Director of the Research Institute of Sant Pau Hospital (IIB-Sant Pau) and director of the Movement Disorders Unit at the Neurology Department of Sant Pau Hospital. He is Full Professor of Neurology and Vice-Dean at the Autonomous University of Barcelona.
Dr Kulisevsky is the PI of the Parkinson’s disease (PD) area of the Spanish Biomedical Network Research Centre for Neurodegenerative Diseases (CIBERNED-Instituto de Salud Carlos III) and is involved in many IP-initiated and Industry-sponsored trials in PD and parkinsonism.
He is the Spanish coordinator of the European Huntington Disease Network (EHDN), Member of the Executive Committee of the EHDN, Coordinator of the Cognitive Phenotype Working Group of the EHDN and the current PI in Spain for the Enroll-HD study.
He has been recipient of several public research grants as well as being involved in a wide range of clinical trials as Principal Investigator. His particular research interest refers to the cognitive and behavioural consequences of Parkinson’s disease, Parkinsonism and other basal ganglia disorders. In this line, Dr. Kulisevsky has authored more than 250 papers in peer-reviewed journals.
Prof. Dr. Jaime Kulisevsky is presently Director of the Research Institute of Sant Pau Hospital (IIB-Sant Pau) and director of the Movement Disorders Unit at the Neurology Department of Sant Pau Hospital. He is Full Professor of Neurology and Vice-Dean at the Autonomous University of Barcelona.
Dr Kulisevsky is the PI of the Parkinson’s disease (PD) area of the Spanish Biomedical Network Research Centre for Neurodegenerative Diseases (CIBERNED-Instituto de Salud Carlos III) and is involved in many IP-initiated and Industry-sponsored trials in PD and parkinsonism.
He is the Spanish coordinator of the European Huntington Disease Network (EHDN), Member of the Executive Committee of the EHDN, Coordinator of the Cognitive Phenotype Working Group of the EHDN and the current PI in Spain for the Enroll-HD study.
He has been recipient of several public research grants as well as being involved in a wide range of clinical trials as Principal Investigator. His particular research interest refers to the cognitive and behavioural consequences of Parkinson’s disease, Parkinsonism and other basal ganglia disorders. In this line, Dr. Kulisevsky has authored more than 250 papers in peer-reviewed journals.
